Healthcare's AI race heats up
Eli Lilly is testing a new weight loss drug called retatrutide, and other companies like Ro are taking advantage of AI in their health tech products.
The healthcare industry is witnessing a surge in the race to adopt artificial intelligence (AI). Ro, a digital healthcare company, is at the forefront of this trend as it introduces an AI agent to assist with patient care. CEO Zach Reitano discussed this new development with Business Insider's Hilary Brueck, highlighting how Ro's digital assistant can leverage patient data, such as prescription info or wearable device readings, to offer personalized health recommendations and adjust medication dosages accordingly.
The battle for supremacy in AI-powered healthcare is heating up as traditional healthcare providers and AI giants compete to develop the most innovative solutions. Ro's advantage lies in its deep understanding of the healthcare landscape and access to vast amounts of patient data. However, this advantage is offset by the lack of technical expertise compared to AI-focused companies.
Conversely, AI companies possess powerful technology stacks but often lack the specialized medical knowledge required for effective application.
This competitive landscape extends beyond healthcare, as data has emerged as a critical resource across various industries. The challenge for both healthcare and AI companies is striking a balance between utilizing patient data while adhering to stringent privacy regulations and maintaining high standards of patient care. In the healthcare sector, where the stakes are incredibly high, navigating this delicate equilibrium proves particularly complex.
To address these challenges, AI companies like OpenAI have even enlisted medical experts to guide their development and ensure responsible use of AI in the medical field. As the healthcare AI race intensifies, companies must find ways to effectively harness the power of artificial intelligence while prioritizing patient safety and regulatory compliance.
Written by urgent.news from Business Insider's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
